Dr. Scott Fountain recently joined Charles River as the executive director of North American laboratory sciences and clinical support. Dr. Fountain received his PhD in analytical chemistry from the University of Michigan and, following graduation, joined Waters Corporation in a technical client-facing role. After his appointment at Waters, Dr. Fountain joined Pfizer Inc., establishing a quantitative biomarker implementation group at Pfizer Michigan and later a biotherapeutics and translational research group at Pfizer California, the latter integrating quantitative analytics with mathematical modeling and simulation methodologies. Dr. Fountain’s interest in applied laboratory science and pharmaceutical research helped shape a professional career of over 20 years, including volunteer work with the American Association of Pharmaceutical Scientists, where he is the incoming AAPS BIOTEC Section Chair for 2017.
In his new role, Dr. Fountain will ensure the quality and alignment of the laboratory sciences across all of our relevant units and sites. He will also lead important initiatives to maintain our position as the industry’s scientific leader in laboratory sciences and clinical support, as well as play an interfacing role with many of Charles River's key safety assessment clients.